Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease

Jong Hwa Choi, Won Sohn, Yong Kyun Cho

Clin Mol Hepatol. 2020;26(4):662-669. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0163

View: 8504 Download: 164 Web of Science: 32 Crossref: 32

Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies

Seung Ha Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(4):652-661. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0160

View: 5112 Download: 102 Web of Science: 16 Crossref: 19

3

Effects of Genetic Polymorphisms of Ethanol-Metabolizing Enzymes on Alcohol Drinking Behaviors

Joo Young Kee, M.D., Min Ok Kim, M.D., Il Young You, M.D., Ji Young Chai, M.D., Eui Sil Hong, M.D., Sung Chul An, M.D. Heon Kim, M.D. Seon Mee Park, M.D., Sei Jin Youn, M.D. and Hee Bok Chae, M.D.

Clin Mol Hepatol. 2003;9(2):89-97. Published online January 1, 1970

View: 2810 Download: 38

1 |

Viewed By 5349	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5300	MAFLD: How is it different from NAFLD?
Viewed By 5198	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3888	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3844	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search